People form the core of our success
Scientists and employees
leadXpro’s team of more than 35 experts originates from 13 different countries. Over 60% of our team members hold PhDs, combining diverse scientific backgrounds and a wealth of industry experience.
Board of Directors
Michael Hennig
CEO and chairman of the board
Structural biologist and senior drug discovery executive. Previously, global leader discovery technologies at Roche.
Rafael Abela
Board of Directors
Physicist at the PSI, scientific project leader for the SLS and SwissFEL projects.
Michael Milos
Board of Directors
Molecular Biologist, life-cycle management in drug development at Actelion, project management at Vaxxilon and co-founder of AVANTECA Partners.
John Millard
Board of Directors
Chemical engineering, MBA at London Business School, positions at BP, ABB, Enron and other companies, co-founder of two companies. Since 2018 Head of Technology Transfer Management at PSI
Andreas Insam
Board of Directors
Doctor in political economics, University of Innsbruck. Previously CEO of Bendura Bank, previously Board member of LGT Bank.
